Press Releases

Press Releases

  • August 3, 2017
    Aileron Therapeutics to Present at Canaccord Genuity 37th Annual Growth Conference
  • June 28, 2017
    Aileron Therapeutics Announces Pricing of Initial Public Offering
  • June 15, 2017
    Aileron Therapeutics Appoints Donald Dougherty as Senior Vice President and Chief Financial Officer
  • June 3, 2017
    Anti-tumor Activity Observed in Phase 1 Trial of Novel P53-Targeting Drug ALRN-6924
  • May 18, 2017
    Aileron Therapeutics Announces Oral Presentation at ASCO on ALRN-6924 Targeting p53